Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
40.0%
% of MEDX's 30 holdings also in FTXH
24.0%
% of FTXH's 51 holdings also in MEDX
Overlap by Weight
Sector Drift (MEDX minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
ABBVIE INC | 9.6% | 7.4% | 7.4% |
|
BRISTOL-MYERS SQUIBB CO | 6.5% | 7.6% | 6.5% |
|
JOHNSON & JOHNSON | 5.1% | 7.5% | 5.1% |
|
PFIZER INC | 4.0% | 7.2% | 4.0% |
|
AMGEN INC | 6.3% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
MEDX Overweight Relative to FTXH
|
ELI LILLY & CO | 13.4% |
 |
NOVARTIS AG-ADR | 6.6% |
 |
ASTRAZENECA PLC-SPONS ADR | 5.6% |
|
ALNYLAM PHARMACEUTICALS INC | 4.1% |
 |
ALKERMES PLC | 3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 2.7% |
|
AMGEN INC | 2.5% |
|
CRISPR THERAPEUTICS AG | 2.4% |
|
IONIS PHARMACEUTICALS, INC. | 2.4% |
|
ABBVIE INC | 2.2% |
MEDX Underweight Relative to FTXH
|
GILEAD SCIENCES INC | -3.7% |
|
ZOETIS INC | -3.7% |
|
MERCK & CO. INC. | -3.6% |
|
UNITED THERAPEUTICS CORP | -3.6% |
|
VIATRIS, INC. | -3.3% |
|
JAZZ PHARMACEUTICALS PLC | -3.2% |
|
PFIZER INC | -3.2% |
|
ORGANON & CO. | -2.6% |
|
JOHNSON & JOHNSON | -2.4% |
|
CHARLES RIVER LABORATORIES | -2.0% |